Conditions: Type1 Diabetes Mellitus
Interventions: Drug: Dapagliflozin 5mg; Drug: Placebo Oral Tablet
Sponsors: University of California, San Diego; Juvenile Diabetes Research Foundation
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.